Lee's Pharmaceutical Holdings Limited

DB:L1PA Stock Report

Market Cap: €100.9m

Lee's Pharmaceutical Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:L1PA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Sep 24Buy€7,686Wanee LeelalertsuphakunIndividual56,500€0.14
09 Jul 24Buy€6,750Wanee LeelalertsuphakunIndividual50,000€0.14
08 Jul 24Buy€6,946Wanee LeelalertsuphakunIndividual52,000€0.13
28 Jun 24Buy€13,925Wanee LeelalertsuphakunIndividual100,000€0.14
19 Jun 24Buy€14,312Wanee LeelalertsuphakunIndividual100,000€0.14
17 Jun 24Buy€9,901Wanee LeelalertsuphakunIndividual72,500€0.14
11 Jun 24Buy€1,083Wanee LeelalertsuphakunIndividual7,500€0.14
07 Jun 24Buy€7,225Wanee LeelalertsuphakunIndividual50,000€0.14
06 Jun 24Buy€7,177Wanee LeelalertsuphakunIndividual50,000€0.14
03 May 24Buy€4,698Wanee LeelalertsuphakunIndividual33,500€0.14
02 May 24Buy€15,605Wanee LeelalertsuphakunIndividual114,000€0.14
30 Apr 24Buy€920Wanee LeelalertsuphakunIndividual7,000€0.13
25 Jan 24Buy€8,085Wanee LeelalertsuphakunIndividual50,000€0.16
23 Jan 24Buy€4,794Wanee LeelalertsuphakunIndividual30,000€0.16
20 Jan 24Buy€14,482Wanee LeelalertsuphakunIndividual90,000€0.16
12 Jan 24Buy€7,609Wanee LeelalertsuphakunIndividual45,000€0.17
11 Jan 24Buy€3,434Wanee LeelalertsuphakunIndividual20,000€0.17
10 Jan 24Buy€8,801Wanee LeelalertsuphakunIndividual53,500€0.16

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of L1PA?
Owner TypeNumber of SharesOwnership Percentage
Institutions41,432,8467.04%
Individual Insiders69,337,76611.8%
VC/PE Firms83,985,00014.3%
General Public150,740,72125.6%
Private Companies243,339,01041.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 21 shareholders own 74.4% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.4%
Huby Technology Limited
114,000,625€19.5m0%no data
12%
Apta Finance S.A.
70,676,577€12.1m0%no data
9.99%
Xiaoyi Li
58,815,266€10.1m0%no data
9.25%
GL Capital Group
54,485,000€9.3m0%3.51%
5.28%
Gortune International Investment Holding Limited
31,076,999€5.3m0%no data
5.01%
Panacea Venture Management Co., Ltd.
29,500,000€5.1m0%11.04%
4.98%
UBS Asset Management AG
29,330,425€5.0m-0.81%no data
3.68%
Gl Healthcare Investment LP
21,680,488€3.7m0%no data
1.43%
Wanee Leelalertsuphakun
8,402,500€1.4m1.93%no data
1.09%
Dimensional Fund Advisors LP
6,428,639€1.1m0%no data
1%
Aptafin S.p.A.
5,904,321€1.0m0%no data
0.89%
Lion River I N.V.
5,239,512€897.7k0%0.99%
0.14%
Siu Fong Lee
800,000€137.1k-0.11%no data
0.088%
Yau Ching Chan
520,000€89.1k0%no data
0.085%
Zuie-Chin Huang
500,000€85.7k0%no data
0.051%
Wah Keung Tsim
300,000€51.4k0%no data
0.038%
Acadian Asset Management LLC
224,715€38.5k-5.45%no data
0.015%
SEI Investments Management Corporation
86,110€14.7k-27.2%no data
0.012%
LD Pensions
73,444€12.6k0%no data
0.0085%
Fidelity International Ltd
50,000€8.6k0%no data
0%
Credit Suisse, Investment Banking and Securities Investments
1€00%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 22:33
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lee's Pharmaceutical Holdings Limited is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason Cheng3V Capital Limited
Yue-Kwong LuiBOCOM International Securities Limited
Chu WangCitigroup Inc